Validity of the SNOT-22 as a Primary Outcome in Recurrent Acute Rhinosinusitis

Дата публикации: 08-10-2026 00:00:00

To the Editor In their randomized clinical trial, Kaski et al evaluated endoscopic sinus surgery for recurrent acute rhinosinusitis (RARS). This is an important area of research, given the limited high-quality evidence available, and the authors should be commended for their study. However, I believe there is an important flaw in their methods that that deserves further discussion.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Validity of the SNOT-22 as a Primary Outcome in Recurrent Acute Rhinosinusitis—Reply	0	6.5	08-10-2026
2	Facial Synkinesis Resting Phenotypes and Surgical Implications	0	11.34	15-10-2026
3	Is ROSA Always Reliable? High Accuracy but Notable Deviations in Medial Tibial Resection and Femoral Component Sizing in Mechanically-Aligned Total Knee Arthroplasty	0	16.19	20-08-2026
4	Diverse Research Teams and Underrepresented Groups in Clinical Studies	0	6.4	01-11-2023
5	Asymptomatic Carotid Stenosis	0	5.78	01-04-2026
6	Transvaginal Drainage vs Laparoscopy for Tubo-Ovarian Abscess	0	11.86	23-09-2026
7	Twenty-Five–Year Follow-Up of Quantified Mitral Regurgitation	0	15.41	29-07-2026
8	Ocular Symptoms After Refractive Surgery	0	5	09-07-2026
9	Diagnostic Accuracy of Retinal Birefringence vs Traditional Autorefraction	0	5.52	01-07-2026
10	Detecting Glaucoma in Myopic Eyes With OCT	0	7	02-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.05. Источник: jamanetwork.com.